An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

Recently, metastatic renal cell carcinoma (mRCC) treatment has changed dramatically with the onset of new therapies against molecular targets replacing immunotherapy as standard treatment. We report the case of a 49-year-old patient with a moderately differentiated renal clear cell carcinoma without...

Full description

Bibliographic Details
Main Authors: Chara, Luis, Rodríguez, Beatriz, Holgado, Esther, Ramírez, Natalia, Fernández-Rañada, Isabel, Mohedano, Nicolás, Arcediano, Alberto, García, Inés, Cassinello, Javier
Format: Online
Language:English
Published: S. Karger AG 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251249/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251249/

Similar Items